IGI Logo
Toggle Navigation
News
Hindi
Hindi News
Top News
Screeners
Stocks
Stocks Screener
Stock
News
Stock Market Home Page
Stock News
Industry News
Economy News
Stock on the move
Expert Views
Research Reports
Company Result
Comp Info And Fundamentals
Company Profile
Equity
Financial Ratios
Results
Balance Sheet
Profit And Loss
Cash Flow
Share Holding
Derivatives (F&O)
Get Quotes
Market Watch
Top Gainers
Top Losers
Top Traded Quantity
Top Traded Value
Most Active Puts
Derivatives (F&O)
Most Active Calls
Put Call Ratio
Highest In Premium
Daily Settlement Price
FII and DII Statistics
Open Interest: Highest In OI
Open Interest: Lowest In OI
Derivatives (F&O)
Open Interest: Increase in OI Increase in Price
Open Interest: Decline in OI Decrease in Price
Derivative Watch
Derivatives Dashboard
Historical Data
List of Underlyings & Underlying Info
Derivative Watch
Derivatives Dashboard
Market Reports
Top Gainers
Top Losers
Monthly High/Low
52 Week High
52 Week Low
Market Cap Gainers
Market Cap Losers
PE Ratio
>More Market Reports
IPO
News
IPO News
IPO Issue Reports
Commodity
Commodity Market
Commodity Home Page
Commodity News
Commodity Reports
Market Details
Get Quotes
Top Gainers
Top Losers
Top Volume
Top Value
Top Gainers Spot Market
Top Losers Spot Market
High & Low
Commodity Indices
Technical Analysis
Advance Declines
High & Low
Highest In OI
Lowest OI
Increase In Open Interest(%)
Descrease In Open Interest(%)
Currency
News
Currency News
Economy News
Currency Reports
Mutual Fund
News
Mutual Fund Home Page
Mutual Fund News
Mutual Fund Details
Mutual Fund Home Page
Compare Scheme
Scheme Profile
Mutual fund Investment
Mutual Fund Share Holding
Mutual Fund Statistics
Mutual fund Gainers
Mutual fund Losers
Biggest Schemes
Best Performers
Latest Dividend Details
Tools
Multi Scheme Comparison Tool
Dividend Details
Performance Map
Mutual fund Investment
Mutual fund Share Holding
Mutual Fund Search Category Rankings
Widgets
Stock Widgets
Watchlist
Heatmap
Mutual Fund Widgets
Watchlist
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
Wealth
World
Tips
Intraday Tips
Market Outlook
Stock Tips
Commodity Tips
Currency Tips
Reports
Short Term Investment Opportunities
Long Term Investment Opportunities
Sector Analysis
Commodity Reports
Currency Reports
Mutual Fund Analysis
Podcast
Videos
Videos Category
Business Videos
Budget Videos
News And Politics
Entertainment Videos
Sports Videos
Lifestyle And Fashion Videos
Global News Videos
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
More
Budget 2024
Astrology
Women
Politics
Entertainment
Car&Bike
Gadgets
Lifestyle
Sports
Health
Fashion
Diwali Reports
Diwali Expert Reports
News
Astrology
Beyond Market Car
Beyond Market Entertainment
Beyond Market Fashion
Beyond Market Gadgets
Beyond Market Health
Beyond Market India
Beyond Market Life Style
Beyond Market Sports
Broking Firm Views
Broking Firm Views - Long Term Report
Broking Firm Views - Sector Report
Broking Firm Views - Short Term Report
Budget 2024 Sector Reports
Budget Bites
Budget Economic Servey
Budget Expert Views
Budget Industry
Budget News
Budget Wishlist
Commodities
Commodities Reports
Commodity Top News
Company News
Company Result
Currency News
Currency Report
Currency Top News
Diwali Expert Views
Diwali Market Outlook
Diwali Report
Diwali Technical Report
Economy News
Expert View Institution
Expert Views
Industry News
IPO Analysis
IPO More News
IPO Reports
IPO Top News
Market Outlook
Mutual Fund Analysis
Mutual Fund Expert Views
Mutual Fund More News
Mutual Fund Top News
Podcast - Market Ki Awaaz
Special Event Expert Views
Special Event Reports
Startup
Startup Expections
Startup Speak
Stock Market
Stock On The Move
Top News
Top Stories
Videos
Videos Business
Videos Entertainment
Videos Global News
Videos Lifestyle And Fashion
Videos News And Politics
Videos Sports
Wealth
Women
World Market More News
World Top News
Search
Jubilant Ingrevia is currently trading at Rs. 404.70, up by 6.35 points or 1.59% from its previous closing of Rs. 398.35 on the BSE. The scrip opened at Rs. 400.00 and has touched a high and low of Rs. 405.70 and Rs. 397.85 respectively. So far 2849 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 350.80 on 29-Mar-2023. Last one week high and low of the scrip stood a...
Jubilant Ingrevia soars on raising Rs 100 crore via commercial papers
India's Jubilant Ingrevia Ltd on Tuesday reported an almost 24% slump in fourth-quarter profit as lower chemicals price and sustained challenges in the supplements business dented revenue. Consolidated net profit fell to 523.1 million rupees ($6.4 million) for the three months ended March 31 from 685.9 million rupees a year earlier, marking the fourth straight quarter of earnings drop. Margins on the earnings before interest, taxes, depreciation and amortisation (EBITDA) shrank to 9...
India`s Jubilant Ingrevia posts Q4 profit slump as supplements faced headwinds
Jubilant Ingrevia is currently trading at Rs. 431.20, up by 1.25 points or 0.29% from its previous closing of Rs. 429.95 on the BSE. The scrip opened at Rs. 430.05 and has touched a high and low of Rs. 434.35 and Rs. 428.00 respectively. So far 7178 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 350.80 on 29-Mar-2023. Last one week high and low of the scrip stood a...
Jubilant Ingrevia gains on raising Rs 50 crore via commercial papers
Jubilant Ingrevia is currently trading at Rs. 401.45, up by 2.85 points or 0.72% from its previous closing of Rs. 398.60 on the BSE. The scrip opened at Rs. 398.60 and has touched a high and low of Rs. 404.75 and Rs. 388.85 respectively. So far 34547 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 350.80 on 29-Mar-2023. Last one week high and low of the scrip stood ...
Jubilant Ingrevia gains on commissioning new Acetic Anhydride plant in Gujarat
Jubilant Ingrevia is currently trading at Rs. 412.90, up by 15.60 points or 3.93% from its previous closing of Rs. 397.30 on the BSE. The scrip opened at Rs. 400.45 and has touched a high and low of Rs. 420.20 and Rs. 400.45 respectively. So far 13370 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 395.65 on 16-Mar-2023. Last one week high and low of the scrip stood...
Jubilant Ingrevia moves higher on acquiring 37.98% stake in Mister Veg Foods
Jubilant Ingrevia is currently trading at Rs. 469.50, up by 0.55 points or 0.12% from its previous closing of Rs. 468.95 on the BSE. The scrip opened at Rs. 467.20 and has touched a high and low of Rs. 476.00 and Rs. 465.10 respectively. So far 73755 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 401.35 on 08-Mar-2022. Last one week high and low of the scrip stood ...
Jubilant Ingrevia gains on raising Rs 150 crore via CPs
Federal Bank * Federal bank is one of India's largest old generation private sector banks. At the end of Q2 FY2023 the bank had advances of Rs. 1.61 lakh cr. And deposits of Rs 1.89 lakh cr. The bank predominantly has a secured lending book which helped limit asset quality issues during the Covid 19 pandemic. * Federal Bank has posted a good set of numbers for Q2FY23 as NII, and Advances increased by 19.1%/19.9% YoY. Provisioning for the quarter was up by mere 9% YoY because of whic...
Diwali Fundamental Muhurat Picks By Angel One
Jubilant Ingrevia is currently trading at Rs. 474.90, up by 3.55 points or 0.75% from its previous closing of Rs. 471.35 on the BSE. The scrip opened at Rs. 468.00 and has touched a high and low of Rs. 483.90 and Rs. 467.75 respectively. So far 18256 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 877.95 on 18-Oct-2021 and a 52 week low of Rs. 401.35 on 08-Mar-2022. Last one week high and low of the scrip stood ...
Jubilant Ingrevia surges on raising Rs 50 crore via CPs
Jubilant Ingrevia has raised Rs 25 crore through Commercial Papers (CPs) on July 15, 2022. Date of maturity of said Commercial Papers will be August 30, 2022. Tenure of the instrument of this Commercial Papers is 46 days. Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
Jubilant Ingrevia raises Rs 25 crore through Commercial Papers
The company reported standalone net profit of Rs 74.48 crore for the quarter ended March 31, 2022 as compared to Rs 38.59 crore in the same period last year, registering a year-on-year growth of 93.00 per cent. Net revenue of the company rose substantially by 87.97 per cent at Rs 1,247.69 crore in January-March quarter of this fiscal as against Rs 663.77 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 93.35 per cent to Rs 1,106.15 ...
Jubilant Ingrevia Q4 net profit jumps 93.00% at Rs 74.48 cr
Jubilant Ingrevia (‘Ingrevia’) came out with its Q2FY22 results, which showed significant QoQ de-growth in absolute EBITDA and margins on the back Acetyls (LS Chem EBITDA 14% vs 27% QoQ). Large part of sequential decline was on account of Inventory gains in Q1FY22 and reduction in % spreads. As per us, Q2FY22 can be considered as base for absolute EBITDA in acetyls while the margins may continue to decline on the back of higher Acetic acid prices. Spec Chem margins declined on the...
Buy Jubilant Ingrevia Ltd For Target Rs.1040 - Monarch Networth Capital
Our Take: Jubilant Ingrevia has presence across mainly three segments Speciality Chemicals (33% of revenue), Nutrition and Health Solutions (18%) and Life Science Chemicals (49%), with strong backward integration and a leading market position. About 25% of Life Science Chemicals (LSC) volumes and 45% of pyridine and picolines (speciality chemicals) are consumed in house, leading to retaining of higher profit across the value chain. During FY21, the company derived about 54% of its revenue ...
Update On Jubilant Ingrevia Ltd By HDFC Securities
Key News Restructuring plan: Ford India talks up compensation with dealer partners Ford India on Wednesday met its principal dealers to work out a compensation formula as it prepares to exit India's automobile market as part of a restructuring it announced on September 9. Most of the company's 170 dealers signed a non-disclosure agreement – a precondition set by the company to start negotiations. The day-long meeting hosted by Anurag Mehrotra, Ford India managing director,...
Key News - Jubilant Ingrevia Ltd, Mindtree, Hero Electric, Axis Bank By ARETE Securities
Emargin Positional Pick Buy Jubilant Ingrevia Ltd For Target Rs. 950 - HDFC Securities TECHNICAL OBSERVATIONS * Stock price has broken out on the daily chart with higher volumes. * Stock price is forming bullish higher top higher bottom formation on the daily and weekly chart. * Short term trend of the Stock is positive where it is trading above its 5 and 20 day EMA * RSI oscillator is placed above 60 and rising upwards, Indicating strength in the...
Emargin Positional Pick Buy Jubilant Ingrevia Ltd For Target Rs. 950 - HDFC Securities
Key Meeting Takeaways Specialty segment: * CDMO Expansion: Multiproduct facility for Pharma & Crop Protection customers, diketene derivatives and agro actives ( for pesticides) will start in the next 2 years with capex of ~Rs 550cr years in 3 years’ time. Growth will be higher and margins are expected to improve in 3-5 years’ time in the segment. Nutrition & Health solutions: * Expand Vitamin B3 capacity by ~20% from current 13,000 MT/ Year and launch...
Buy Jubilant Ingrevia Ltd For Target Rs.770 - Monarch Networth Capital
Technical Positional Pick - Buy Jubilant Ingrevia Ltd For Target Rs. 800 - HDFC Securities TECHNICAL OBSERVATIONS * Stock price has broken out on the daily chart with higher volumes. * Short term trend of the stock is positive where it is trading above its 5 and 20 and 50 day EMA. * Oscillators like RSI and MFI is showing strength in the stock. * Plus DI is trading above Minus DI, Indicating strength in the current uptrend. * Considering the Technic...
Technical Positional Pick - Buy Jubilant Ingrevia Ltd For Target Rs. 800 - HDFC Securities
First Cut: Extremely encouraging performance on the back of Acetyls and Specialty Segment Ingrevia trades at ~11.4x FY23E EV/EBITDA. Given that Specialty and Nutrition business contributes >70% of our FY23E EBITDA, we believe there is room for further re-rating * Financial Performance - Sales at INR 1145crs up 6% QoQ / 55% YoY - EBITDA at INR 287crs up 43% QoQ / 126% YoY - EBITDA margins 25% vs 19% QoQ - Inventory gains of INR ~63crs; adjusting which EBITDA margins at 20% ...
Buy Jubilant Ingrevia Ltd For Target Rs.770 - Monarch Networth
Below are Quote on Jubilant Ingrevia Ltd -1QFY22 - Result Update by Mr. Amarjeet Maurya, AVP - Mid Caps, Angel Broking Ltd Jubilant Ingrevia Ltd (JIL) 1QFY2022 results outperformed the estimates. The top-line grew by ~55% YoY to Rs1,145cr on the back of robust growth in volume and prices. On segment wise, Speciality Chemicals revenue grew by ~18% yoy, Nutrition and Health Solutions revenue grew by ~13% yoy and Life Sciences Chemical revenue grew by ~103% yoy.On the EBI...
Quote on Jubilant Ingrevia Ltd -1QFY22 - Result Update By Mr. Amarjeet Maurya, Angel Broking Ltd
Load More